INTRODUCTION
============

Wound contaminants are likely to originate from three main sources: 1) the environment e.g. exogenous microorganisms in the air or those introduced by traumatic injury, 2) the surrounding skin and 3) endogenous sources involving mucous membranes \[[@R1]\]. *Staphylococcus aureus* is an important cause of human infections ranging from mild to life-threatening and is frequently isolated from chronic leg ulcers \[[@R2]\]. *S. aureus* inhabit multiple sites of the skin and mucosal surfaces of carriers; however, the primary reservoir of staphylococci is believed to be the anterior nares.*S. aureus* nasal carriage is a major risk factor for both community-acquired and nosocomial infections and there seems to be an epidemiological link between nasal carriage and infections with *S. aureus* \[[@R3]-[@R7]\].

The purpose of this study was to investigate whether the bacterial species found in chronic leg ulcers were also present in the nasal cavity of the same patient.

Sixteen patients admitted to the Copenhagen Wound Healing Center, Bispebjerg Hospital, Denmark were included in the study. The patients suffered from persistent venous leg ulcers and all patients had previously been part of the SUE project \[[@R2]\]. A swab was taken from the ulcer and the nasal cavity of the patients. The swab was immediately placed in SSI Stuart transport medium (SSI 28733, Denmark) and processed the same day as collected.

Media and agar plates were purchased from Statens Serum Institut (SSI), Denmark. Swabs were cultured as described before \[[@R2]\]. All representative colonies were isolated and identified by standard microbiological methods, and where appropriate, commercial identification kits were used to assist identification (VITEK GNI+, ID 32 Kits, BioMerieux, France).

All *S. aureus* strains found in this study and the SUE study \[[@R2]\] were tested. A bacterial suspension yielding semi-confluent growth was spread on a susceptibility 5 % blood agar plate (SSI 723, Denmark) with the following NeoSensitabs (Rosco, Taastrup, Denmark): cefoxitin, penicillin, gentamicin, mecillinam, erythromycin, polymyxin, fucidin, vancomycin and rifampicin. Plates were incubated overnight at 37ºC, and inhibition zones were measured. Susceptibility interpretations were based on the manufacturer's recommendations.

All *S. aureus* strains were characterized by pulse-field gel electrophoresis (PFGE) after digestion with *Sma*I as described by Skov *et al*., 2005 \[[@R8]\].

*S. aureus* was found in 13 of the 16 ulcers. Six out of the 13 patients also harboured *S. aureus* in the nasal cavity. *Klebsiella oxytoca* was found in the ulcer and the nose of one patient, but besides this no other bacterial species isolated from the ulcers were found to be present in the nasal cavity. To the best of our knowledge, this is the first study on the possible transmission of *S. aureus* from the nasal cavity to chronic leg ulcers.

Fig. (**[1](#F1){ref-type="fig"}**) shows the PFGE analysis of *Sma*I restriction fragments from patients harbouring *S. aureus* both in the nasal cavity and the leg ulcer. The figure reveals that these patients had the same type both places, thereby suggesting cross contamination between the nasal cavity and the leg ulcer. The PFGE type of the *S. aureus* isolates from the nasal cavity and leg ulcers of patient 4 and patient 5 was found to be identical. We cannot preclude that the strain had been transmitted from one patient to the other at the hospital premises. The result of the PFGE analysis is shown in Fig. (**[1](#F1){ref-type="fig"}**). None of the *S. aureus* strains isolated from the chronic ulcers or the nasal cavity were found to be methicillin-resistant (MRSA). The strains isolated from the nasal cavity and the leg ulcers had identical resistance patterns. All isolates were sensitive to erythromycin, gentamicin, vancomycin and rifampicin and resistant to penicillin, mecillinam and polymyxin. Mecillinam and polymyxin are in general not considered to be functional against Gram positive bacterae. In one case the isolates from the nasal cavity and leg ulcer from the same patient were resistant to fucidin, while the remaining isolates were sensitive. These results are in accordance with the resistance profiles of 271 *S. aureus* isolates inhabiting chronic leg ulcer, which we also investigated (see Table **[1](#T1){ref-type="table"}**). In this study we did not find any methicillin resistant*S. aureus* (MRSA). While MRSA is an increasing problem globally, the prevalence of MRSA in Denmark is quite low; in the period of 2005-2009 all departments of clinical microbiology in Denmark reported on *S. aureus* bacteraemia cases 6912 times; only 1.3 % exhibited resistance to methicillin \[[@R9]\].

Bacterial species isolated from chronic ulcers were not found to be present in the nasal cavity except for the *S. aureus* strains and in one case; *K. oxytoca*. This indicates that the ulcer microbiota in general does not originate from the nasal cavity of the patients, with the exception of *S. aureus*. However, it is not possible to rule out the possibility that the nasal cavity might have been an intermediate reservoir at some time point for other bacterial species than *S. aureus*.

*S. aureus* was detected in the nasal cavity of 38% of the patients, moreover *S. aureus* were found in 81 % of the leg ulcers identified using swab collections. We have recently shown that it is sufficient to use swab sampling to identify the bacterial species present in chronic wounds, thus avoiding complications associated with biopsy sampling \[[@R10]\]. The patients had the same *S. aureus* PFGE type in leg ulcers and nasal cavities, which indicates that cross-contamination between the ulcers and the nasal cavity occurs. Previous studies have shown that *S. aureus* originating in the nasal cavity may contaminate e.g. dialysis access sites \[[@R5],[@R6]\]. Our study suggests that the source of contamination of leg ulcers may be the patients' anterior nares and further implicates that removal of infecting *S. aureus* from the leg ulcer may be very difficult if the reservoir (the nasal cavity) remains contaminated.
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Antibiotic-resistance of 271 S. aureus Isolates from Chronic Venous Leg Ulcers

  Antibiotic     Resistant (%)   Intermediary (%)   Sensitive (%)
  -------------- --------------- ------------------ ---------------
  Penicillin     226 (83.4)      10 (3.7)           35 (12.9)
  Erythromycin   23 (8.5)        3 (1.1)            245 (90.4)
  Gentamicin     0 (0.0)         0 (0.0)            271 (100.0)
  Mecillinam     245 (90.4)      11 (4.1)           15 (5.5)
  Polymyxin      271 (100.0)     0 (0.0)            0 (0.0)
  Cefoxitin      0 (0.0)         0 (0.0)            271 (100.0)
  Fucidin        26 (9.6)        44 (16.2)          201 (74.2)
  Vancomycin     0 (0.0)         0 (0.0)            271 (100.0)
  Rifampicin     0 (0.0)         0 (0.0)            271 (100.0)
